Expertise
Medicine & Life Sciences
# Breast Neoplasms
# Mastectomy
# Neoplasms
# Netherlands
# Population
# Recurrence
# Registries
# Survival
Organisations
Ancillary Activities
-
IKNL
senior onderzoeker
Publications
Recent
van Vliet, E. D.
, Eijkelboom, A., van Giessen, A.
, Siesling, S., & de Wit, G. A. (2023).
Physical and mental health outcomes of COVID-19 induced delay in oncological care: A systematic review.
Frontiers in oncology,
13.
https://doi.org/10.3389/fonc.2023.998940
van Maaren, M. C.
, Siesling, S., Hueting, T. A., Völkel, V., van Hezewijk, M., & Strobbe, L. J. A. (2023).
The use and misuse of risk prediction tools for clinical decision-making.
The Breast.
https://doi.org/10.1016/j.breast.2023.01.006
de Maar, J. S., Luyendijk, M., Suelmann, B. B. M., Kruijssen, D. E. W., Elias, S.
, Siesling, S., & Van Der Wall, E. (2023).
Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference—a Dutch population-based study from 2008 to 2018.
Breast cancer research and treatment.
https://doi.org/10.1007/s10549-022-06837-4
't Hart, L. (Author)
, & Siesling, S. (Other). (2023).
Corona heeft kankerzorg veel goeds gebracht: 'Was een ongewilde proeftuin'. Web publication/site
https://www.nu.nl/gezondheid/6247880/corona-heeft-kankerzorg-veel-goeds-gebracht-was-een-ongewilde-proeftuin.html
Poelhekken, K.
, Greuter, M. J. W., de Munck, L.
, Siesling, S., Brokken, F. B., & de Bock, G. H. (2023).
Long-term effects of the interruption of the Dutch breast cancer screening program due to COVID-19: A modelling study.
Preventive medicine,
166, 1-7. [107376].
https://doi.org/10.1016/j.ypmed.2022.107376
Siesling, S. (Author), van der Voort, A. (Author), & de Groot, F. (Author). (2022).
SABCS22 - Neoadjuvante chemotherapie bij borstkanker. Digital or Visual Products
https://www.oncologie.nu/videos/sabcs22-neoadjuvante-chemotherapie-bij-borstkanker/?key=eb327ce63ee26d8&exp=1675281410
Meijer, J. (Author)
, & Siesling, S. (Author). (2022).
SABCS22 - Impact COVID-19-pandemie bij borstkanker. Digital or Visual Products
https://www.oncologie.nu/videos/sabcs22-impact-covid-19-pandemie-bij-borstkanker/
van Steenhoven, J. E. C.
, van Maaren, M. C., Verreck, E. E. F., Schipper, R. J., Nieuwenhuijzen, G. A. P., Kuijer, A.
, Siesling, S., & van Dalen, T. (2022).
Inequalities in the omission of axillary dissection in sentinel lymph node positive patients in the Netherlands: Innovative hospitals are early adopters of a de-escalating approach.
International journal of cancer.
https://doi.org/10.1002/ijc.34400
Siesling, S., & Derksen, J. (2022).
Epidemiologie en risicofactoren van kanker. In H. de Haes, L. Gualtherie, & R. Sanderman (Eds.),
Psychologische patientenzorg in de oncologie: Handboek voor professionals (4e herz. dr. ed., pp. 11-24). Van Gorcum.
Siesling, S. (2022).
Nieuwe tool biedt inzicht in gevolgen borstkanker tot 14 jaar na diagnose.
MedNet Oncologie, (april), 10-10.
UT Research Information System
Courses Academic Year 2022/2023
Courses in the current academic year are added at the moment they are finalised in the Osiris system. Therefore it is possible that the list is not yet complete for the whole academic year.
Courses Academic Year 2021/2022
Contact Details
Visiting Address
University of Twente
Faculty of Behavioural, Management and Social Sciences
Technohal
(building no. 18), room 3105
Hallenweg 5
7522NH Enschede
The Netherlands
Mailing Address
University of Twente
Faculty of Behavioural, Management and Social Sciences
Technohal
3105
P.O. Box 217
7500 AE Enschede
The Netherlands